Literature DB >> 19540601

Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.

Maria Bettini1, Kristen Rosenthal, Brian D Evavold.   

Abstract

XIncreasing evidence supports a role for CD8+ T cells in multiple sclerosis. In an attempt to isolate the contribution of CD8+ T cells in a murine model of MS, we immunized mice with a dominant CD8 epitope MOG37-46, a truncated version of MOG35-55. The data presented here show mild disease induced with MOG37-46, characterized by lower clinical scores, a decrease in CNS infiltration and a decrease in microglial activation. CD8+ T cells reactive to MOG37-46 are pro-inflammatory and traffic to the CNS; however, the presence of CD4+ T cells elicits more severe disease and sustained inflammation of the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540601      PMCID: PMC2752735          DOI: 10.1016/j.jneuroim.2009.05.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  47 in total

1.  Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.

Authors:  Nader Najafian; Tanuja Chitnis; Alan D Salama; Bing Zhu; Christina Benou; Xueli Yuan; Michael R Clarkson; Mohamed H Sayegh; Samia J Khoury
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Vulnerability of human neurons to T cell-mediated cytotoxicity.

Authors:  Fabrizio Giuliani; Cynthia G Goodyer; Jack P Antel; V Wee Yong
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

3.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets.

Authors:  Khairul Bariah Abdul-Majid; Judit Wefer; Christine Stadelmann; Andreas Stefferl; Hans Lassmann; Tomas Olsson; Robert A Harris
Journal:  J Neuroimmunol       Date:  2003-08       Impact factor: 3.478

5.  Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.

Authors:  Cécile Delarasse; Philippe Daubas; Lennart T Mars; Csaba Vizler; Tobias Litzenburger; Antonio Iglesias; Jan Bauer; Bruno Della Gaspera; Anna Schubart; Laurence Decker; Dalia Dimitri; Guy Roussel; Andrée Dierich; Sandra Amor; Andre Dautigny; Roland Liblau; Danielle Pham-Dinh
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

6.  Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.

Authors:  Ying C Q Zang; Sufang Li; Victor M Rivera; Jian Hong; Rachel R Robinson; Wini T Breitbach; James Killian; Jingwu Z Zhang
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

7.  The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice.

Authors:  David Liñares; Paula Mañá; Melinda Goodyear; Anne M Chow; Chelsea Clavarino; Nicholas D Huntington; Louise Barnett; Frank Koentgen; Ryo Tomioka; Claude C A Bernard; Manuel Freire-Garabal; Hugh H Reid
Journal:  J Autoimmun       Date:  2003-12       Impact factor: 7.094

8.  Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice.

Authors:  F Mokhtarian; D E McFarlin; C S Raine
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

9.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Cytotoxic effect of myelin basic protein-reactive T cells on cultured oligodendrocytes.

Authors:  K Kawai; B Zweiman
Journal:  J Neuroimmunol       Date:  1988-08       Impact factor: 3.478

View more
  24 in total

1.  Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.

Authors:  Nathan R York; Jason P Mendoza; Sterling B Ortega; Andrew Benagh; Andrew F Tyler; Mihail Firan; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2010-02-20       Impact factor: 7.094

2.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

Review 3.  Immune tolerance in multiple sclerosis.

Authors:  Joan M Goverman
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

4.  Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.

Authors:  Shannon L McArdel; Daniel R Brown; Raymond A Sobel; Arlene H Sharpe
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

5.  Altered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR.

Authors:  Rajshekhar Alli; Phuong Nguyen; Terrence L Geiger
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

6.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Authors:  Magdalena Huber; Sylvia Heink; Axel Pagenstecher; Katharina Reinhard; Josephine Ritter; Alexander Visekruna; Anna Guralnik; Nadine Bollig; Katharina Jeltsch; Christina Heinemann; Eva Wittmann; Thorsten Buch; Olivia Prazeres da Costa; Anne Brüstle; Dirk Brenner; Tak W Mak; Hans-Willi Mittrücker; Björn Tackenberg; Thomas Kamradt; Michael Lohoff
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

7.  An ανβ3 integrin-binding peptide ameliorates symptoms of chronic progressive experimental autoimmune encephalomyelitis by alleviating neuroinflammatory responses in mice.

Authors:  Fan Zhang; Jing Yang; Hong Jiang; Shu Han
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-28       Impact factor: 4.147

8.  The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis.

Authors:  Sterling B Ortega; Venkatesh P Kashi; Andrew F Tyler; Khrishen Cunnusamy; Jason P Mendoza; Nitin J Karandikar
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

9.  NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.

Authors:  Lori Blanchfield; Joseph J Sabatino; Laurel Lawrence; Brian D Evavold
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

10.  Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8⁺ T cells derived from autoantigen-deficient mice.

Authors:  Melanie D Leech; Antonio Carrillo-Vico; Roland S Liblau; Stephen M Anderton
Journal:  Front Immunol       Date:  2011-05-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.